Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV

Mark S. Sulkowski,Kenneth E. Sherman,Douglas T. Dieterich,Mohammad Bsharat,Lisa Mahnke,Jürgen K. Rockstroh,Shahin Gharakhanian,Scott McCallister,Joshua Henshaw,Pierre-Marie Girard,Bambang S. Adiwijaya,Varun Garg,Raymond A. Rubin,Nathalie Adda,Vincent Soriano

Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV

2020

Mark S. Sulkowski
Kenneth E. Sherman
Douglas T. Dieterich
Mohammad Bsharat
Lisa Mahnke
Jürgen K. Rockstroh
Shahin Gharakhanian
Scott McCallister
Joshua Henshaw
Pierre-Marie Girard
Bambang S. Adiwijaya
Varun Garg
Raymond A. Rubin
Nathalie Adda
Vincent Soriano

In this small randomized trial of patients with both genotype 1 hepatitis C virus and HIV, adding telaprevir to peginterferon-α2a (PEG-IFN-α2a)–ribavirin therapy produced a greater sustained virolo...

Keywords:

Internal medicine
Viral load
Randomized controlled trial
Virology
Hepatitis C virus
Combination therapy
Adverse effect
Virus
Genotype
Telaprevir
Medicine
Cardiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations